Page last updated: 2024-10-25

clioquinol and Blastocystis hominis Infections

clioquinol has been researched along with Blastocystis hominis Infections in 1 studies

Clioquinol: A potentially neurotoxic 8-hydroxyquinoline derivative long used as a topical anti-infective, intestinal antiamebic, and vaginal trichomonacide. The oral preparation has been shown to cause subacute myelo-optic neuropathy and has been banned worldwide.
5-chloro-7-iodoquinolin-8-ol : A monohydroxyquinoline that is quinolin-8-ol in which the hydrogens at positions 5 and 7 are replaced by chlorine and iodine, respectively. It has antibacterial and atifungal properties, and is used in creams for the treatment of skin infections. It has also been investigated as a chelator of copper and zinc ions for the possible treatment of Alzheimer's disease.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
van Hellemond, JJ1
Molhoek, N1
Koelewijn, R1
Wismans, PJ1
van Genderen, PJ1

Other Studies

1 other study available for clioquinol and Blastocystis hominis Infections

ArticleYear
Is paromomycin the drug of choice for eradication of Blastocystis in adults?
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2013, Volume: 19, Issue:3

    Topics: Adult; Amebicides; Blastocystis Infections; Clioquinol; Cohort Studies; Disease Eradication; Female;

2013